期刊文献+

卡马西平、丙戊酸钠对甲状旁腺功能及骨密度的影响 被引量:2

The effect of carbamazepine and valproate on function of parathyroid and bone mineral density
下载PDF
导出
摘要 目的:探讨两种主要抗癫痫药(ADEs)卡马西平(CBZ)及丙戊酸钠(VPA)对甲状旁腺功能及骨密度(BMD)的影响,旨在为预防药物引起的继发甲状旁腺功能亢进和骨质疏松提供参考。方法:观察了60例年龄在18-40岁间确诊的癫痫患者。30例单独服用丙戊酸钠,30例单独服用卡马西平,时间≥6个月。50例正常成人对照组,每组男女各半。3组均测定其血清甲状旁腺激素(iPTH)、降钙素(CT)、血清钙(Ca^2+)、血清磷(P^3+)、碱性磷酸酶(ALP);分别进行骨密度的测定。结果:卡马西平组血清Ca^2+、P^3+的浓度均较正常对照组低,丙戊酸组血清Ca^2+的浓度较正常对照组高。在这两组中血清PTH、CT、ALP的浓度均较正常对照组高。两组患者的骨密度均出现不同程度的减低。结论:卡马西平和丙戊酸均可引起血VFH、CT的异常增高和骨密度的降低,最终导致继发甲状旁腺功能亢进或骨质疏松。 Aim: To examine the effect of carbamazepine and valproate monotherapy on secondary hyperparathyroidism and bone mineral density in adult. Methods: Thirty adult patients aged 18 -40 years old with epilepsy were treated with VPA alone for over 6 months. Thirty age-matched adults with epilepsy taking CBZ as monotherapy for more than 6 months; and 50 the same age-range and sex-matched volunteers serving as controls. Serum concentrations of calcium ( Ca^2 + ), phosphate ( p^3 +), intact parathyroid hormone( iPTH), Calcitonin(CT) and alkaline phosphatase (ALP) and bone mineral density were examined in all patients and control. Results: Serum concentrations of Ca^2+, P^3+ were significant lower in CBZ group than control group, serum concentrations of Ca^2+ in patients on VPA were significant higher than in CBZ group and control groups. And seru concentrations of ALP, iPTH and CT were pronounced higher in both CBZ group and VPA group than control. Conclusion:Secondary hyperparathyroidism and decrease of bone mineral density can be caused by CBZ and VPA .
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2008年第2期194-196,共3页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 广东省卫生厅基金资助项目[WSTJJ20021113430105196312263050(A316)]
关键词 抗癫痫药 继发甲状旁腺功能亢进 骨密度 antiepileptic drug secondary hyperparathyroidism bone mineral density
  • 相关文献

参考文献8

  • 1VOUDRIS K, MOUSTAKI M, ZEIS P M,et al. Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapy [ J ]. Seizure, 2002,11 (6) :377 - 380.
  • 2张素华 沈鼎烈 邱鸿鑫 等.抗癫痫药所致钙磷代谢紊乱及骨矿含量改变[J].中华神经精神科杂志,1988,21:129-131.
  • 3GUO C Y, RONEN G M, ATKINSON S A, et al. Long- term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy[J]. Epilepsia, 2001,42(9):1141 -1147.
  • 4VILLALPANDO S, CAMPOS-PAHUA J, ESQUIVEL S, et al. Serum parathormone, 25 hydroxycholecalciferol and magnesium concentrations in infants with seizures associated with spontaneous hypocalcemia[ J]. Arch Invest Med (Mex) 1988,19(2):165 -171.
  • 5AKIN R, OKUTAN V, SARICI U, et al. Evaluation of bone minral density in children receiving antiepilepticdrugs [J]. Pediatr Neurol,1998,19(2) :129 -131.
  • 6SATO Y, KONDO I, ISHIDA S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy[ J ]. Neurology, 2001, 57 ( 3 ) : 445 - 449.
  • 7刘中厚,主编.骨质疏松学[M].北京:科学出版社,1998.174—175.
  • 8POOLE K E, REEVES J, WAR.BURTON E A. Falls, fractures, and osteoporosis after stroke:time to think about protection? [ J ]. Stroke, 2002, 33 ( 1 ) : 1432 - 1436.

共引文献5

同被引文献25

  • 1杨斌,陈向涛,汪惠丽,徐广珍.丙戊酸对癫痫患儿骨代谢的影响[J].儿科药学杂志,2005,11(6):5-7. 被引量:7
  • 2林苗,朱珠.新型抗癫痫药的安全性评价[J].药物不良反应杂志,2006,8(2):81-87. 被引量:19
  • 3Verrotti A, Agostinelli S, Coppola G, et al. A 12 - month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy [ J ]. Eur J Neurol,2010,17 ( 2 ) :232 - 237.
  • 4Krishnamoorthy G , Karande S, Ahire N ,et al. Bone metabolism alteration on antiepileptic drug therapy[ J ]. Indian J Pediatr, 2009,76 (4) : 377 - 383.
  • 5Rauchenzauner M, Griesmacher A, Tatarczyk T, et al. Chronic antiepileptic monotherapy,bone metabolism, and body composition in non - institutionalized children[ J ]. Dev Med Child Neurol, 2009,52 ( 3 ) : 283 - 288.
  • 6Ferin M, Morrell M, Xiao E,et al. Endocrine and metabolic responses to long - term monotherapy with the antiepileptic drug valproate in thenormally cycling rhesus monkey [ J ]. J Clin Endocrinol Metab, 2003,88 (6) :2908 -2915.
  • 7Nakken KO,Tauboll E. Bone loss associated with use of antiepileptic drugs[J].Expert Opin Drug Saf,2010,9(4) :1 - 11.
  • 8Fuleihan G, Nabulsi M,Tamin H, et al. Effect of vitamin D replacement on musculoskelctal parameters in school children:A randomized controlled trial [ J]. J Clin Endocrinol Metab ,2006,91 ( 2 ) :405 - 412.
  • 9Mikati MA, Dib L,Yamout B,et al. Two randomized vitamin D trials in ambulatory patients on anticonvulsants[J]. Neurology,2006,67 ( 11 ) : 2005 - 2014.
  • 10Phabphal K, Geater A, Leelawattana R, et al. Prevalence and risk fac- tors of low bone mineral density and 25 - hydroxyvitamin D status in young healthy epileptic adult patients in a tropical Asian country taking antiepileptic drug [ J ]. Bone, 2009,45 ( 2 ) : 232 - 237.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部